# Filing Detail

Form 10-KT - Transition reports [Rule 13a-10 or 15d-10]:
SEC Accession No. 0001213900-20-007501
Filing Date
2020-03-26
Accepted
2020-03-26 16:10:15
Documents
70
Period of Report
2019-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | TRANSITION REPORT | f10kt2019_relmadatherape.htm | 10-KT | 1315389
2 | CONSENT OF MARCUM LLP | f10kt2019ex23-1_relmada.htm | EX-23.1 | 2227
3 | CERTIFICATION | f10kt2019ex31-1_relmada.htm | EX-31.1 | 7700
4 | CERTIFICATION | f10kt2019ex31-2_relmada.htm | EX-31.2 | 7765
5 | CERTIFICATION | f10kt2019ex32-1_relmada.htm | EX-32.1 | 3435
6 | CERTIFICATION | f10kt2019ex32-2_relmada.htm | EX-32.2 | 3357
| Complete submission text file | 0001213900-20-007501.txt |  | 5100378

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE FILE | rlmd-20191231.xml | EX-101.INS | 773933
8 | XBRL SCHEMA FILE | rlmd-20191231.xsd | EX-101.SCH | 60074
9 | XBRL CALCULATION FILE | rlmd-20191231_cal.xml | EX-101.CAL | 48257
10 | XBRL DEFINITION FILE | rlmd-20191231_def.xml | EX-101.DEF | 233376
11 | XBRL LABEL FILE | rlmd-20191231_lab.xml | EX-101.LAB | 434104
12 | XBRL PRESENTATION FILE | rlmd-20191231_pre.xml | EX-101.PRE | 323815

Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-KT | Act: 34 | File No.: 001-39082 | Film No.: 20746246
SIC: 2834 Pharmaceutical Preparations